Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Psychiatric Quarterly
Erschienen in: Psychiatric Quarterly 1/2012

01.03.2012 | Original Article

Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity

verfasst von: Jessica R. Jackson, William W. Eaton, Nicola G. Cascella, Alessio Fasano, Deanna L. Kelly

Erschienen in: Psychiatric Quarterly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Celiac Disease (CD) is an immune-mediated disease dependent on gluten (a protein present in wheat, rye or barley) that occurs in about 1% of the population and is generally characterized by gastrointestinal complaints. More recently the understanding and knowledge of gluten sensitivity (GS), has emerged as an illness distinct from celiac disease with an estimated prevalence 6 times that of CD. Gluten sensitive people do not have villous atrophy or antibodies that are present in celiac disease, but rather they can test positive for antibodies to gliadin. Both CD and GS may present with a variety of neurologic and psychiatric co-morbidities, however, extraintestinal symptoms may be the prime presentation in those with GS. However, gluten sensitivity remains undertreated and underrecognized as a contributing factor to psychiatric and neurologic manifestiations. This review focuses on neurologic and psychiatric manifestations implicated with gluten sensitivity, reviews the emergence of gluten sensitivity distinct from celiac disease, and summarizes the potential mechanisms related to this immune reaction.
Literatur
1.
Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 120:636–651, 2001PubMedCrossRef
2.
Bizzaro N, Tozzoli R, Villalta D, Fabris M, Tonutti E: Cutting-edge issues in celiac disease and in gluten intolerance. Clinical Reviews in Allergy and Immunology 2010. doi:10.​1007/​s12016-010-8223-1
3.
Hadjivassiliou M, Grunewald RA, Davies-Jones GA: Gluten sensitivity as a neurological illness. Journal of Neurology, Neurosurgery and Psychiatry 72:560–563, 2002CrossRef
4.
Hadjivassiliou M, Williamson CA, Woodroofe N: The immunology of gluten sensitivity: Beyond the gut. Trends in Immunology 25:578–582, 2004PubMedCrossRef
5.
Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Carteni M, Casolaro V, et al.: Differential mucosal IL-17 expression in two gliadin-induced disorders: Gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy and Immunology 152:75–80, 2010PubMedCrossRef
6.
Kaukinen K, Turjanmaa K, Maki M, Partanen J, Venalainen R, Reunala T, et al.: Intolerance to cereals is not specific for coeliac disease. Scandinavian Journal of Gastroenterology 35:942–946, 2000PubMedCrossRef
7.
8.
Dohan FC: Wheat “consumption” and hospital admissions for schizophrenia during World War II. A preliminary report. American Journal of Clinical Nutrition 18:7–10, 1966PubMed
9.
Briani C, Zara G, Alaedini A, Grassivaro F, Ruggero S, Toffanin E, et al.: Neurological complications of celiac disease and autoimmune mechanisms: A prospective study. Journal of Neuroimmunology 195:171–175, 2008PubMedCrossRef
10.
Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, Davies-Jones GA, Gibson A, Jarratt JA, et al.: Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 352:1582–1585, 1998PubMedCrossRef
11.
Hadjivassiliou M, Grunewald R, Sharrack B, Sanders D, Lobo A, Williamson C, et al.: Gluten ataxia in perspective: Epidemiology, genetic susceptibility and clinical characteristics. Brain 126:685–691, 2003PubMedCrossRef
12.
Bhatia KP, Brown P, Gregory R, Lennox GG, Manji H, Thompson PD, et al.: Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 118 (Pt 5):1087–1093, 1995PubMedCrossRef
13.
Hadjivassiliou M, Boscolo S, Davies-Jones GA, Grunewald RA, Not T, Sanders DS, et al.: The humoral response in the pathogenesis of gluten ataxia. Neurology 58:1221–1226, 2002PubMed
14.
Hadjivassiliou M, Kandler RH, Chattopadhyay AK, Davies-Jones AG, Jarratt JA, Sanders DS, et al.: Dietary treatment of gluten neuropathy. Muscle and Nerve 34:762–766, 2006PubMedCrossRef
15.
Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P: Idiopathic cerebellar ataxia associated with celiac disease: Lack of distinctive neurological features. Journal of Neurology, Neurosurgery and Psychiatry 66:32–35, 1999CrossRef
16.
Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A, et al.: Celiac neuropathy. Neurology 60:1581–1585, 2003PubMed
17.
Chin RL, Latov N, Green PH, Brannagan TH, 3rd, Alaedini A, Sander HW: Neurologic complications of celiac disease. Journal of Clinical Neuromuscular Disease 5:129–137, 2004PubMedCrossRef
18.
Morris JS, Ajdukiewicz AB, Read AE: Neurological disorders and adult coeliac disease. Gut 11:549–554, 1970PubMedCrossRef
19.
Pfaender M, D’Souza WJ, Trost N, Litewka L, Paine M, Cook M: Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: A case series. Journal of Neurology, Neurosurgery and Psychiatry 75:1623–1625, 2004CrossRef
20.
Arroyo HA, De Rosa S, Ruggieri V, de Davila MT, Fejerman N: Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in childhood. Journal of Child Neurology 17:800–806, 2002PubMedCrossRef
21.
Hernandez MA, Colina G, Ortigosa L: Epilepsy, cerebral calcifications and clinical or subclinical coeliac disease. Course and follow up with gluten-free diet. Seizure 7:49–54, 1998
22.
Canales P, Mery VP, Larrondo FJ, Bravo FL, Godoy J: Epilepsy and celiac disease: Favorable outcome with a gluten-free diet in a patient refractory to antiepileptic drugs. Neurologist 12:318–321, 2006PubMedCrossRef
23.
Cernibori A, Gobbi G: Partial seizures, cerebral calcifications and celiac disease. Italian Journal of Neurological Sciences 16:187–191, 1995PubMedCrossRef
24.
Fois A, Vascotto M, Di Bartolo RM, Di Marco V: Celiac disease and epilepsy in pediatric patients. Child’s Nervous System 10:450–454, 1994PubMedCrossRef
25.
Peltola M, Kaukinen K, Dastidar P, Haimila K, Partanen J, Haapala AM, et al.: Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity. Journal of Neurology, Neurosurgery and Psychiatry 80:626–630, 2009CrossRef
26.
Hadjivassiliou M, Rao DG, Wharton SB, Sanders DS, Grunewald RA, Davies-Jones AG: Sensory ganglionopathy due to gluten sensitivity. Neurology 75:1003–1008, 2010PubMedCrossRef
27.
Hadjivassiliou M, Chattopadhyay AK, Grunewald RA, Jarratt JA, Kandler RH, Rao DG, et al.: Myopathy associated with gluten sensitivity. Muscle and Nerve 35:443–450, 2007PubMedCrossRef
28.
Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, et al.: Association between migraine and Celiac disease: Results from a preliminary case-control and therapeutic study. American Journal of Gastroenterology 98:625–629, 2003PubMedCrossRef
29.
Poloni N, Vender S, Bolla E, Bortolaso P, Costantini C, Callegari C: Gluten encephalopathy with psychiatric onset: Case report. Clinical Practice and Epidemiology in Mental Health 5:16, 2009PubMedCrossRef
30.
Kieslich M, Errazuriz G, Posselt HG, Moeller-Hartmann W, Zanella F, Boehles H: Brain white-matter lesions in celiac disease: A prospective study of 75 diet-treated patients. Pediatrics 108:E21, 2001PubMedCrossRef
31.
Addolorato G, Capristo E, Ghittoni G, Valeri C, Masciana R, Ancona C, et al.: Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: A longitudinal study. Scandinavian Journal of Gastroenterology 36:502–506, 2001PubMedCrossRef
32.
Cicarelli G, Della Rocca G, Amboni M, Ciacci C, Mazzacca G, Filla A, et al.: Clinical and neurological abnormalities in adult celiac disease. Neurological Sciences 24:311–317, 2003PubMedCrossRef
33.
Carta MG, Hardoy MC, Boi MF, Mariotti S, Carpiniello B, Usai P: Association between panic disorder, major depressive disorder and celiac disease: A possible role of thyroid autoimmunity. Journal of Psychosomatic Research 53:789–793, 2002PubMedCrossRef
34.
Niederhofer H, Pittschieler K: A preliminary investigation of ADHD symptoms in persons with celiac disease. Journal of Attention Disorders 10:200–204, 2006PubMedCrossRef
35.
Genuis SJ, Bouchard TP: Celiac disease presenting as autism. Journal of Child Neurology 25:114–119, 2010PubMedCrossRef
36.
De Santis A, Addolorato G, Romito A, Caputo S, Giordano A, Gambassi G, et al.: Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: Regression after a gluten-free diet. Journal of Internal Medicine 242:421–423, 1997PubMedCrossRef
37.
Samaroo D, Dickerson F, Kasarda DD, Green PH, Briani C, Yolken RH, et al.: Novel immune response to gluten in individuals with schizophrenia. Schizophrenia Research 118:248–255, 2010PubMedCrossRef
38.
Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophrenia Research 37:94–100, 2011
39.
Addolorato G, Mirijello A, D’Angelo C, Leggio L, Ferrulli A, Vonghia L, et al.: Social phobia in coeliac disease. Scandinavian Journal of Gastroenterology 43:410–415, 2008PubMedCrossRef
40.
Hauser W, Janke KH, Klump B, Gregor M, Hinz A: Anxiety and depression in adult patients with celiac disease on a gluten-free diet. World Journal of Gastroenterology 16:2780–2787, 2010PubMedCrossRef
41.
Ludvigsson JF, Reutfors J, Osby U, Ekbom A, Montgomery SM: Coeliac disease and risk of mood disorders—a general population-based cohort study. Journal of Affective Disorders 99:117–126, 2007PubMedCrossRef
42.
Ruuskanen A, Kaukinen K, Collin P, Huhtala H, Valve R, Maki M, et al.: Positive serum antigliadin antibodies without celiac disease in the elderly population: Does it matter? Scandinavian Journal of Gastroenterology 45:1197–1202, 2010PubMedCrossRef
43.
Corvaglia L, Catamo R, Pepe G, Lazzari R, Corvaglia E: Depression in adult untreated celiac subjects: Diagnosis by the pediatrician. American Journal of Gastroenterology 94:839–843, 1999PubMedCrossRef
44.
Atladottir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B, Eaton WW, et al.: Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124:687–694, 2009PubMedCrossRef
45.
Valicenti-McDermott MD, McVicar K, Cohen HJ, Wershil BK, Shinnar S: Gastrointestinal symptoms in children with an autism spectrum disorder and language regression. Pediatric Neurology 39:392–398, 2008PubMedCrossRef
46.
de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric and Gastroenterology Nutrition 51:418–424, 2010CrossRef
47.
Knivsberg AM, Reichelt KL, Hoien T, Nodland M: A randomised, controlled study of dietary intervention in autistic syndromes. Nutritional Neuroscience 5:251–261, 2002PubMedCrossRef
48.
Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, Parlar S, Jacobsen J, et al.: The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutritional Neuroscience 13:87–100, 2010PubMedCrossRef
49.
Hsu CL, Lin CY, Chen CL, Wang CM, Wong MK: The effects of a gluten and casein-free diet in children with autism: A case report. Chang Gung Medical Journal 32:459–465, 2009PubMed
50.
Vojdani A, O’Bryan T, Green JA, McCandless J, Woeller KN, Vojdani E, et al.: Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutritional Neuroscience 7:151–161, 2004PubMedCrossRef
51.
Kalaydjian AE, Eaton W, Cascella N, Fasano A: The gluten connection: The association between schizophrenia and celiac disease. Acta Psychiatrica Scandinavica 113:82–90, 2006PubMedCrossRef
52.
Graff H, Handford A: Celiac syndrome in the case histories of five schizophrenics. Psychiatric Quarterly 35:306–313, 1961PubMedCrossRef
53.
Dohan FC, Grasberger JC, Lowell FM, Johnston HT, Jr., Arbegast AW: Relapsed schizophrenics: More rapid improvement on a milk- and cereal-free diet. British Journal of Psychiatry 115:595–596, 1969PubMedCrossRef
54.
Dohan FC, Grasberger JC: Relapsed schizophrenics: Earlier discharge from the hospital after cereal-free, milk-free diet. American Journal of Psychiatry 130:685–688, 1973PubMed
55.
Singh MM, Kay SR: Wheat gluten as a pathogenic factor in schizophrenia. Science 191:401–402, 1976PubMedCrossRef
56.
Dohan FC, Levitt DR, Kushnir LD: Abnormal behavior after intracerebral injection of polypeptides from wheat gliadin: Possible relevance to schizophrenia. Pavlovian Journal of Biological Science 13:73–82, 1978PubMedCrossRef
57.
Rice JR, Ham CH, Gore WE: Another look at gluten in schizophrenia. American Journal of Psychiatry 135:1417–1418, 1978PubMed
58.
Vlissides DN, Venulet A, Jenner FA: A double-blind gluten-free/gluten-load controlled trial in a secure ward population. British Journal of Psychiatry 148:447–452, 1986PubMedCrossRef
59.
Potkin SG, Weinberger D, Kleinman J, Nasrallah H, Luchins D, Bigelow L, et al.: Wheat gluten challenge in schizophrenic patients. American Journal of Psychiatry 138:1208–1211, 1981PubMed
60.
Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, et al.: Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophrenia Bulletin 37:94–100, 2011PubMedCrossRef
61.
Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Leister F, et al.: Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biological Psychiatry 68:100–104, 2010PubMedCrossRef
62.
Jin SZ, Wu N, Xu Q, Zhang X, Ju GZ, Law MH, et al. A study of circulating gliadin antibodies in schizophrenia among a Chinese population. Schizophrenia Bulletin 2010. doi:10.​1093/​schbul/​sbq111
63.
Reichelt KL, Landmark J: Specific IgA antibody increases in schizophrenia. Biological Psychiatry 37:410–413, 1995PubMedCrossRef
64.
Boscolo S, Sarich A, Lorenzon A, Passoni M, Rui V, Stebel M, et al.: Gluten ataxia: Passive transfer in a mouse model. Annals of the New York Academy of Sciences 1107:319–328, 2007PubMedCrossRef
65.
Sander HW, Magda P, Chin RL, Wu A, Brannagan TH, 3rd, Green PH, et al.: Cerebellar ataxia and coeliac disease. Lancet 362:1548, 2003PubMedCrossRef
66.
Burk K, Melms A, Schulz JB, Dichgans J: Effectiveness of intravenous immunoglobin therapy in cerebellar ataxia associated with gluten sensitivity. Annals of Neurology 50:827–828, 2001PubMedCrossRef
67.
Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D: Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Annals of Neurology 64:332–343, 2008PubMedCrossRef
68.
Alaedini A, Okamoto H, Briani C, Wollenberg K, Shill HA, Bushara KO, et al.: Immune cross-reactivity in celiac disease: Anti-gliadin antibodies bind to neuronal synapsin I. Journal of Immunology 178:6590–6595, 2007
69.
Palova-Jelinkova L, Rozkova D, Pecharova B, Bartova J, Sediva A, Tlaskalova-Hogenova H, et al.: Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. Journal of Immunology 175:7038–7045, 2005
70.
Thomas KE, Sapone A, Fasano A, Vogel SN: Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: Role of the innate immune response in Celiac disease. Journal of Immunology 176:2512–2521, 2006
71.
Ashkenazi A, Krasilowsky D, Levin S, Idar D, Kalian M, Or A, et al.: Immunologic reaction of psychotic patients to fractions of gluten. American Journal of Psychiatry 136:1306–1309, 1979PubMed
72.
Pavol MA, Meyers CA, Rexer JL, Valentine AD, Mattis PJ, Talpaz M: Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia. Neurology 45:947–950, 1995PubMed
73.
Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al.: The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine 107:293–300, 1987PubMed
74.
Hadjivassiliou M: Glutamic acid decarboxylase as a target antigen in gluten sensitivity: The link to neurological manifestations? Proceedings of the 11th International Symposium on Celiac Disease. Belfast, 2004
75.
Williamson S, Faulkner-Jones BE, Cram DS, Furness JB, Harrison LC: Transcription and translation of two glutamate decarboxylase genes in the ileum of rat, mouse and guinea pig. Journal of the Autonomic Nervous System 55:18–28, 1995PubMedCrossRef
76.
Volta U, De Giorgio R, Granito A, Stanghellini V, Barbara G, Avoni P, et al.: Anti-ganglioside antibodies in coeliac disease with neurological disorders. Digestive and Liver Diseases 38:183–187, 2006CrossRef
77.
Santoro M, Thomas FP, Fink ME, Lange DJ, Uncini A, Wadia NH, et al.: IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Annals of Neurology 28:373–377, 1990PubMedCrossRef
78.
Molander M, Berthold CH, Persson H, Andersson K, Fredman P: Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody. Journal of Neurocytology 26:101–111, 1997PubMedCrossRef
79.
Hadjivassiliou M, Maki M, Sanders DS, Williamson CA, Grunewald RA, Woodroofe NM, et al.: Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 66:373–377, 2006PubMedCrossRef
80.
Pynnonen PA, Isometsa ET, Verkasalo MA, Kahkonen SA, Sipila I, Savilahti E, et al.: Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: A prospective follow-up case-series study. BMC Psychiatry 5:14, 2005PubMedCrossRef
81.
Hallert C, Sedvall G: Improvement in central monoamine metabolism in adult coeliac patients starting a gluten-free diet. Psychological Medicine 13:267–271, 1983PubMedCrossRef
Metadaten
Titel
Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity
verfasst von
Jessica R. Jackson
William W. Eaton
Nicola G. Cascella
Alessio Fasano
Deanna L. Kelly
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 1/2012
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-011-9186-y

Weitere Artikel der Ausgabe 1/2012

Psychiatric Quarterly 1/2012 Zur Ausgabe

Original Paper

Determinants Associated with the Utilization of Primary and Specialized Mental Health Services

Original Paper

HON Label and DISCERN as Content Quality Indicators of Health-Related Websites

Original Paper

Patients’ Preference and Experiences of Forced Medication and Seclusion

Original Paper

Gene-Environment Interaction and the Intergenerational Transmission of Parenting: Testing the Differential-Susceptibility Hypothesis

Original Paper

Prevalence and Comorbidity of Prolonged Grief Disorder in a Sample of Caregivers of Patients in a Vegetative State

Original Paper

Predictors of Rehospitalization in High-Utilizing Patients in the VA Psychiatric Medical System

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise